FRANKFURT, July 01 (Reuters): French drugmaker Sanofi is nearing a decision to invest between 1.3 billion euros and 1.5 billion euros ($1.4-$1.6 billion) at a major production site in Frankfurt, Germany, where it makes insulin brand Lantus, newspaper Handelsblatt reported on Monday.
The paper cited German government sources as saying Sanofi changed course after initial considerations to transfer Lantus production to France and the company is now close to committing to an upgrade of the German site in Frankfurt's Hoechst district.
A government spokesperson said Chancellor Olaf Scholz was "very much looking forward" to further development but it was for the company to provide an update.
Sanofi to invest $1.6b in Germany
FE Team | Published: July 01, 2024 21:37:06
Sanofi to invest $1.6b in Germany
Share if you like